Venture Partner
Kalos VenturesCheck size: Kalos Ventures does not publish a standard check-size range; it targets a concentrated portfolio of at least 15 companies.
Josh Golomb invests or supports investments through Kalos Ventures's published strategy: Lead early-stage investments in purpose-driven technology companies using AI, automation and robotics to address demographic change across workforce, care and education.
Purpose-driven founders with early product-market fit, strong references and technology that can widen economic opportunity or well-being at scale.
The published strategy concentrates on workforce, care and education around Seed+ and Series A; opportunities outside those themes or without early fit are less aligned.
Connect the demographic change to a large market, show early product-market fit, responsible technology use, founder references and why Kalos should lead and join the board.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Josh Golomb is listed by Kalos Ventures as Venture Partner. Former CEO of Hazel Health and Everside Health and a co-founder of DaVita.